Literature DB >> 22872730

Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series.

Julie A Boom1, Leila C Sahni, Daniel C Payne, Rashi Gautam, Freda Lyde, Slavica Mijatovic-Rustempasic, Michael D Bowen, Jacqueline E Tate, Marcia A Rench, Jon R Gentsch, Umesh D Parashar, Carol J Baker.   

Abstract

Vaccine or vaccine-reassortant rotavirus strains were detected in fecal specimens from 5 of 106 (4.7%) immunocompetent children who required treatment for rotavirus gastroenteritis at a large pediatric hospital in Texas in 2009-2010. Four strains were related to pentavalent rotavirus vaccine, whereas one was related to monovalent rotavirus vaccine. The contribution of these strains to each patient's illness was unclear given that 2 patients had prominent respiratory symptoms and 2 were concurrently infected with another pathogen (group F adenovirus and norovirus). Continued monitoring is necessary to assess the role of vaccine strains and vaccine-reassortant strains in pediatric rotavirus infections.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22872730      PMCID： PMC4618559          DOI： 10.1093/infdis/jis490

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  10 in total

1.  Comparative evaluation of Taqman real-time PCR and semi-nested VP1 PCR for detection of enteroviruses in clinical specimens.

Authors:  M Steven Oberste; Silvia Peñaranda; Shannon L Rogers; Elizabeth Henderson; W Allan Nix
Journal:  J Clin Virol       Date:  2010-07-27       Impact factor: 3.168

2.  United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.

Authors:  Jennifer J Hull; Elizabeth N Teel; Tara K Kerin; Molly M Freeman; Mathew D Esona; Jon R Gentsch; Margaret M Cortese; Umesh D Parashar; Roger I Glass; Michael D Bowen
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

3.  Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins.

Authors:  Luis Rivera; Lourdes Mendez Peña; Isabelle Stainier; Paul Gillard; Brigitte Cheuvart; Igor Smolenov; Eduardo Ortega-Barria; Htay Htay Han
Journal:  Vaccine       Date:  2011-10-18       Impact factor: 3.641

4.  Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens.

Authors:  W Allan Nix; M Steven Oberste; Mark A Pallansch
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

5.  Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing.

Authors:  W Allan Nix; Kaija Maher; Mark A Pallansch; M Steven Oberste
Journal:  J Clin Virol       Date:  2010-05-15       Impact factor: 3.168

6.  Two out of the 11 genes of an unusual human G6P[6] rotavirus isolate are of bovine origin.

Authors:  Jelle Matthijnssens; Mustafizur Rahman; Marc Van Ranst
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

7.  Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine.

Authors:  Catherine Yen; Kathleen Jakob; Mathew D Esona; Ximara Peckham; John Rausch; Jennifer J Hull; Susan Whittier; Jon R Gentsch; Philip LaRussa
Journal:  Vaccine       Date:  2011-04-06       Impact factor: 3.641

Review 8.  Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine.

Authors:  Norma Santos; Yasutaka Hoshino
Journal:  Rev Med Virol       Date:  2005 Jan-Feb       Impact factor: 6.989

9.  Detection of all known parechoviruses by real-time PCR.

Authors:  W Allan Nix; Kaija Maher; E Susanne Johansson; Bo Niklasson; A Michael Lindberg; Mark A Pallansch; M Steven Oberste
Journal:  J Clin Microbiol       Date:  2008-06-04       Impact factor: 5.948

10.  Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis.

Authors:  Daniel C Payne; Kathryn M Edwards; Michael D Bowen; Erin Keckley; Jody Peters; Mathew D Esona; Elizabeth N Teel; Diane Kent; Umesh D Parashar; Jon R Gentsch
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124
  10 in total
  24 in total

1.  Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model.

Authors:  Miaoge Xue; Linqi Yu; Lianzhi Jia; Yijian Li; Yuanjun Zeng; Tingdong Li; Shengxiang Ge; Ningshao Xia
Journal:  Hum Vaccin Immunother       Date:  2016-07-19       Impact factor: 3.452

Review 2.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

3.  An infant with acute gastroenteritis caused by a secondary infection with a Rotarix-derived strain.

Authors:  Naomi Sakon; Ryohei Miyamoto; Jun Komano
Journal:  Eur J Pediatr       Date:  2017-07-21       Impact factor: 3.183

4.  Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).

Authors:  David O Matson; Timo Vesikari; Penelope Dennehy; Michael D Dallas; Michelle G Goveia; Robbin F Itzler; Max Ciarlet
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Multiple Introductions and Antigenic Mismatch with Vaccines May Contribute to Increased Predominance of G12P[8] Rotaviruses in the United States.

Authors:  Kristen M Ogden; Yi Tan; Asmik Akopov; Laura S Stewart; Rendie McHenry; Christopher J Fonnesbeck; Bhinnata Piya; Maximilian H Carter; Nadia B Fedorova; Rebecca A Halpin; Meghan H Shilts; Kathryn M Edwards; Daniel C Payne; Mathew D Esona; Slavica Mijatovic-Rustempasic; James D Chappell; John T Patton; Natasha B Halasa; Suman R Das
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

6.  Monitoring Shedding of Five Genotypes of RotaTeq Vaccine Viruses by Genotype-Specific Real-Time Reverse Transcription-PCR Assays.

Authors:  Yuki Higashimoto; Masaru Ihira; Yu Miyazaki; Ayumi Kuboshiki; Sayaka Yoshinaga; Hiroyuki Hiramatsu; Ryota Suzuki; Masafumi Miyata; Hiroki Miura; Satoshi Komoto; Jun Yukitake; Koki Taniguchi; Yoshiki Kawamura; Tetsushi Yoshikawa
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

7.  Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.

Authors:  Xiaobo Wen; Dianjun Cao; Ronald W Jones; Yasutaka Hoshino; Lijuan Yuan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Treatment and prevention of rotavirus infection in children.

Authors:  Penelope H Dennehy
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

9.  Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.

Authors:  N Aliabadi; J E Tate; U D Parashar
Journal:  Clin Microbiol Infect       Date:  2016-04-26       Impact factor: 8.067

10.  Analysis of human rotaviruses from a single location over an 18-year time span suggests that protein coadaption influences gene constellations.

Authors:  Shu Zhang; Paul W McDonald; Travis A Thompson; Allison F Dennis; Asmik Akopov; Ewen F Kirkness; John T Patton; Sarah M McDonald
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.